Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma.
about
BKM120 induces apoptosis and inhibits tumor growth in medulloblastomaMeasuring Kinase Activity-A Global Challenge.Combined c-Met/Trk inhibition overcomes resistance to CDK4/6 inhibitors in Glioblastoma.PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition
P2860
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Combination therapy with poten ...... inical models of glioblastoma.
@en
Combination therapy with poten ...... inical models of glioblastoma.
@nl
type
label
Combination therapy with poten ...... inical models of glioblastoma.
@en
Combination therapy with poten ...... inical models of glioblastoma.
@nl
prefLabel
Combination therapy with poten ...... inical models of glioblastoma.
@en
Combination therapy with poten ...... inical models of glioblastoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Combination therapy with poten ...... linical models of glioblastoma
@en
P2093
Amanda E D Van Swearingen
Carey K Anders
David M Irvin
Demitra A Canoutas
Erik P Sulman
Gary L Johnson
Harshil D Dhruv
Jann N Sarkaria
Jeremy M Simon
Kasey R Skinner
P2860
P304
P356
10.1093/NEUONC/NOX044
P577
2017-10-01T00:00:00Z